Compare GFS & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GFS | HLN |
|---|---|---|
| Founded | 2009 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | 24524 |
| Industry | Semiconductors | Package Goods/Cosmetics |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.2B | 41.1B |
| IPO Year | 2017 | N/A |
| Metric | GFS | HLN |
|---|---|---|
| Price | $75.53 | $9.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $45.08 | N/A |
| AVG Volume (30 Days) | 5.8M | ★ 9.0M |
| Earning Date | 05-05-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.94% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.64 | $6.55 |
| Revenue Next Year | $9.90 | $4.42 |
| P/E Ratio | ★ $29.28 | $49.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $31.51 | $8.65 |
| 52 Week High | $92.55 | $11.28 |
| Indicator | GFS | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 51.27 | 48.07 |
| Support Level | $33.62 | $9.04 |
| Resistance Level | $76.98 | $9.44 |
| Average True Range (ATR) | 5.11 | 0.12 |
| MACD | -0.69 | 0.00 |
| Stochastic Oscillator | 38.13 | 63.27 |
GlobalFoundries is a top-five contract semiconductor manufacturer globally. It was originally the manufacturing arm of Advanced Micro Devices before it was spun out in 2009. The foundry sells chips into a range of end markets including smartphones, PCs, Internet of Things, data centers, automotive, industrial, and so on, but primarily focuses on more mature process technologies. Until 2021, the firm was privately held by Mubadala Investment, the sovereign wealth fund of the United Arab Emirates, which remains its controlling shareholder today. GlobalFoundries merged with Chartered Semiconductor Manufacturing in 2009 and acquired IBM's chipmaking business in 2015. GF is headquartered in Malta, New York, and has about 13,000 staff.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.